Drug that reduces iron levels in affected brain regions has a possible disease-modifying effect in people with multiple system atrophy

HONOLULU, Oct. 5, 2025 /PRNewswire/ — An orally administered drug to redistribute excess iron and lower cellular oxidative stress was found to slow disease progression of multiple system atrophy (MSA), according to a study released at the International Congress of Parkinson’s Disease and…